[-] Show simple item record

dc.contributor.advisorHawley, Kristin M. (Kristin Marie), 1972-eng
dc.contributor.authorKearns, Marciaeng
dc.date.issued2011eng
dc.date.submitted2011 Springeng
dc.descriptionTitle from PDF of title page (University of Missouri--Columbia, viewed on June 2, 2011).eng
dc.descriptionThe entire thesis text is included in the research.pdf file; the official abstract appears in the short.pdf file; a non-technical public abstract appears in the public.pdf file.eng
dc.descriptionThesis advisor: Dr. Kristin Hawley.eng
dc.descriptionIncludes bibliographical references.eng
dc.descriptionM.A. University of Missouri--Columbia 2011.eng
dc.descriptionDissertations, Academic -- University of Missouri--Columbia -- Psychology.eng
dc.description.abstractIn the current study we used a national survey of child psychiatrists to examine typical prescribing practices for children with anxiety, depression, and disruptive behavior disorders from a social judgment theory perspective. We examined the extent to which polypharmacy and off-label prescribing occur in routine practice and the degree to which child characteristics, child psychiatrist characteristics, and medication availability may influence these prescribing practices. We found that child psychiatrists most often prescribed medications that were FDA approved for both age and problem type, and were progressively less likely to choose medications without approval for either age or problem type, and without approval for both age and problem type. We also found that prescribing multiple concomitant medications was the norm. We employed best subsets regression to determine the best subset of theoretically relevant predictors to explain polypharmacy and off-label prescribing. The single best-fitting, theoretically sound model predicting polypharmacy and off-label prescribing of medications included just one predictor variable: total number of diagnoses. These findings suggest that comorbidity is an important issue in the pharmacotherapy of children with mental health disorders that must be addressed in future clinical trials.eng
dc.format.extentvi, 54 pageseng
dc.identifier.urihttp://hdl.handle.net/10355/11178eng
dc.languageEnglisheng
dc.publisherUniversity of Missouri--Columbiaeng
dc.relation.ispartof2011 Freely available theses (MU)eng
dc.relation.ispartofcommunityUniversity of Missouri-Columbia. Graduate School. Theses and Dissertations. Theses. 2011Theseseng
dc.subject.lcshPolypharmacyeng
dc.subject.lcshAnxiety in children -- Chemotherapyeng
dc.subject.lcshDepression in children -- Chemotherapyeng
dc.subject.lcshBehavior disorders in children -- Chemotherapyeng
dc.subject.lcshComorbidityeng
dc.titlePredictors of polypharmacy and off-label prescribing of psychotropic medications: a national survey of child psychiatristseng
dc.typeThesiseng
thesis.degree.disciplinePsychology (MU)eng
thesis.degree.grantorUniversity of Missouri--Columbiaeng
thesis.degree.levelMasterseng
thesis.degree.nameM.A.eng


Files in this item

[PDF]
[PDF]
[PDF]

This item appears in the following Collection(s)

[-] Show simple item record